Chronic tissue inflammation and metabolic disease is a research paper published in Genes & Development (2021). On theSindex it has a DataRank of 0. It has been cited 321 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK033651
National Institutes of Health
Grant: P01DK074868
National Institutes of Health
Grant: P30DK063491
National Institutes of Health
Grant: DK09062
National Institutes of Health
Grant: R01DK124298
NIDDK NIH HHS
Grant: F32 DK009062
Janssen Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 1 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 2 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 2 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 1 of Low-grade inflammation is associated with a heterogeneous lipoprotein subclass profile in an apparently healthy population sample
Additional file 1 of Low-grade inflammation is associated with a heterogeneous lipoprotein subclass profile in an apparently healthy population sample
Additional file 4 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 3 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 4 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
Additional file 3 of Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice